Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.

The bone marrow environment evolves in ways that support the cancer, and I’m a firm believer that to treat cancer effectively ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...

KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master ...

Celularity (CELU) announced a publication in the April 4 issue of peer-reviewed journal Frontiers in Immunology, the official journal of the ...

The following is a summary of “FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 ...

Senti Biosciences, Inc.’s SNTI share price has surged by 8.89%, which has investors questioning if this is right time to sell.

Cord blood units for each cycle, used for the NK cells, were selected from the MD Anderson Cancer Center Cord Blood Bank and chosen based on the criteria previously identified for optimal cord ...